Trisenox and leukopenia Patient Reports February 13, 2012

Trisenox Side Effects Report #4816273-7
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 14, 2005. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cough, crepitations, dyspnoea exertional, haemoglobin decreased, leukopenia, oedema peripheral, petechiae, pitting oedema, platelet count decreased. Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4879520-1
Trisenox side effect was reported by a Physician from JAPAN on Dec 27, 2005. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia, herpes zoster and was treated with Trisenox. After drug was administered, patient experienced the following side effects: leukopenia. Trisenox dosage: 9.765 MG QD INTRAVENOUS DRIP. During the same period patient was treated with BIAPENEM, ACYCLOVIR, FLUCONAZOLE, SULFAMETHOXAZOLE, VERAPAMIL HYDROCHLORIDE. Patient recovered.

Trisenox Side Effects Report #4921173-8
Trisenox side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia, herpes zoster and was treated with Trisenox. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil count decreased. Trisenox dosage: 9.765 MG QD INTRAVENOUS DRIP. During the same period patient was treated with BIAPENEM, ACYCLOVIR, FLUCONAZOLE, SULFAMETHOXAZOLE, VERAPAMIL, ELECTROLYTE REPLACEMENT. Patient recovered.

Trisenox Side Effects Report #4940818-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 23, 2006. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia, thrombocytopenia. Trisenox dosage: 9.765 MG QD INTRAVENOUS DRIP. During the same period patient was treated with BIAPENEM, FLUCONAZOLE, SULFAMETHOXAZOLE, VERAPAMIL HYDROCHLORIDE, UBENIMEX. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #4958112-X
Trisenox side effect was reported by a Physician from JAPAN on Mar 14, 2006. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia, thrombocytopenia. Trisenox dosage: 9.765 MG QD INTRAVENOUS DRIP. During the same period patient was treated with BIAPENEM, FLUCONAZOLE, SULFAMETHOXAZOLE, VERAPAMIL HYDROCHLORIDE, UBENIMEX. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4732841-5
Trisenox side effect was reported by a Physician from JAPAN on July 12, 2005. Female patient, 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, leukopenia, neutropenia. Trisenox dosage: 8.85 MG (8.85 MG), IVI. Patient recovered.

Trisenox Side Effects Report #4848089-X
Trisenox side effect was reported by a Physician from JAPAN on Nov 21, 2005. Female patient, 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, haemoglobin decreased, herpes zoster, leukopenia, neutropenia, neutrophil count decreased, white blood cell count decreased. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4892030-0
Trisenox side effect was reported by a Physician from JAPAN on Jan 10, 2006. Female patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, leukocytosis, leukopenia. Trisenox dosage: 7.32 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #4903384-0
Trisenox side effect was reported by a Physician from JAPAN on Jan 25, 2006. Female patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, leukocytosis, leukopenia. Trisenox dosage: 7.32 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, HEPARIN, IDARUBICIN, FUROSEMIDE. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #5062550-7
Trisenox side effect was reported by a Physician from JAPAN on July 07, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4983248-7
Trisenox side effect was reported by a Physician from JAPAN on Apr 05, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient recovered.

Trisenox Side Effects Report #4996161-6
Trisenox side effect was reported by a Physician from JAPAN on Apr 21, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5030964-7
Trisenox side effect was reported by a Physician from JAPAN on June 05, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.